ESCOP monographs, The Scientific Foundation for Herbal Medicinal Products. Online series. Helichrysi flos (Sandy everlasting flower). Exeter: ESCOP; 2019.
European Scientific Cooperative on Phytotherapy.
ESCOP monographs, The Scientific Foundation for Herbal Medicinal Products. Online series. Helichrysi flos (Sandy everlasting flower). Exeter: ESCOP; 2019.

Helichrysi flos
Sandy everlasting flower
Helichrysum arenarium (L.) Moench
Published 2019
Format: PDF

>> Ver online (30¤ al año, gratis para los socios de SEFIT)

>> Descargar monografía (10¤, para los socios de SEFIT: 8¤)

SUMMARY
The herbal monograph selects and summarises scientific studies and textbooks regarding efficacy, dosage and safety to support the therapeutic uses of Sandy everlasting flower. This herbal drug by definition consists of the whole or cut, dried, fully opened flowers of Helichrysum arenarium (L.) Moench.
Studies with its characteristic constituents flavonoids such as narirutin, naringenin, astragalin are included.
The therapeutic indication is the symptomatic treatment of digestive disorders. In this indication, efficacy was plausible on the basis of human experience and long-standing use.
Administration of sandy everlasting flower addresses posology; its duration of use; contra-indications; special warnings; special precautions for use; interactions with other medicinal products; other forms of interaction; in pregnancy and lactation.
In vitro experiments demonstrated antimicrobial, antioxidant and radical-scavenging, UV-protecting, anti-inflammatory effects and inhibited blood glucose levels.
In vivo experiments with sandy everlasting flower and its extracts showed choleretic, spasmolytic and hypotensive properties in animals.
The selection of literature cited in the monograph is aimed at bringing together relevant information about the possible physiological roles of sandy everlasting flower and its major constituents.

KEYWORDS

  • Helichrysi flos
  • Sandy everlasting flower
  • Helichrysum arenarium (L.) Moench
  • Digestive disorders
  • Symptomatic treatment of digestive disorders
Cita publicaciones
Editores
Bernat Vanaclocha i Vanaclocha
Médico, Colegiado Nº 464610887
Director de Cita Publicaciones y Documentación S.L.

Salvador Cañigueral Folcarà
Unitat de Farmacologia i Farmacognòsia
Facultat de Farmàcia, Universitat de Barcelona